Clinical Trials Browser

Phase 1 × Active not recruiting × talazoparib × Clear all

NCT03974217 2026-02-25

Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia

NCT04846478 2025-04-17

Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC

Phase 1 Active not recruiting

Prostatic Neoplasms